Gilead Sciences Inc. got hit with a $2.5 billion verdict in a patent jury trial against Idenix Pharmaceuticals LLC last year.
But it just dodged a second $2.5 billion bullet on Friday.
U.S. District Judge Leonard Stark in Delaware ruled Friday that Gilead's conduct didn't warrant enhanced damages for willful infringement in a patent fight with Merck subsidiary Idenix.
September 22, 2017 at 08:33 PM
1 minute read
Gilead Sciences Inc. got hit with a $2.5 billion verdict in a patent jury trial against Idenix Pharmaceuticals LLC last year.
But it just dodged a second $2.5 billion bullet on Friday.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS